Miranext 50 Tablet ER
Marketer
Shilpex Pharmysis
Salt Composition
Mirabegron (50mg)
Overview Miranext 50 Tablet ER
Extended-release Miranext 50mg tablets manage overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always follow your doctor's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinue use only under medical supervision, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your physician immediately. Before starting treatment, disclose all other medications and pre-existing conditions, including pregnancy or breastfeeding. Individuals with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.
Uses of Miranext 50 Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Miranext 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Miranext 50 Tablet ER whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, however, consistent daily timing is recommended.
Common Side effects of Miranext 50 Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Miranext 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Miranext 50 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, however, consistent timing is recommended.
How Miranext 50 Tablet ER works:
Extended-release Miranext 50mg tablets function as a beta-3 adrenergic agonist. Their mechanism involves stimulating bladder beta-3 receptors, leading to detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Miranext 50 Tablet ER and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Miranext 50 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Miranext 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Miranext 50 ER tablets.
KidneyCAUTION
Exercise caution when administering Miranext 50 Extended-Release tablets to individuals with advanced renal impairment. Dosage modification of Miranext 50 Extended-Release tablets may be necessary. Seek medical advice.
LiverCAUTION
Patients with liver impairment should use Miranext 50 ER tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Miranext 50 ER tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Miranext 50 Tablet ER :
Should you forget a Miranext 50 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Miranext 50 Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Actions | Beta-3 agonist for bladder control |



